Real-time enrollment status for this hematopoietic and lymphoid cell neoplasm clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:50 AM UTC
| NCT Number | NCT04712539 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | July 16, 2026 (Jul 16, 2026) |
As of September 2, 2026: Clinical trial NCT04712539 is currently recruiting participants. This phase2 study for hematopoietic and lymphoid cell neoplasm is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04712539 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04712539 was last updated Jul 16, 2026 (July 16, 2026). HelloStudys verifies this status automatically.